Bronchodilator responsiveness over 20% was linked to exacerbations and decreased prebronchodilator FEV 1. More patients in this group vs. the low responsiveness group used high-dose inhaled ...

Tozorakimab, an anti-IL-33 antibody, improves lung function and may reduce exacerbations in high-risk COPD patients, early ...

PEF failed to consistently reflect FEV1 improvements after bronchodilation, indicating that handheld spirometry may better ...

HealthDay News — Patients are more likely to have positive bronchodilator responsiveness in the morning and in winter months, according to a study published online March 11 in Thorax.. Ben Knox ...

Bronchodilator responsiveness (BDR) was defined as a 12% improvement over baseline in either FEV1 or FVC, along with an absolute volume increment of 200ml. Peak expiratory flow ...

NEW ORLEANS — Use of spirometry with bronchodilator testing can help reduce overdiagnosis of COPD as well as help differentiate COPD from asthma and asthma-COPD overlap syndrome, researchers ...

Combined treatment with bronchodilator drugs and steroids resulted in a mean increase in vital capacity and first-second volume of almost 50 per cent of the pretreatment value.

Little Evidence Behind Bronchodilator Therapy For Cystic Fibrosis. ScienceDaily . Retrieved May 15, 2025 from www.sciencedaily.com / releases / 2005 / 10 / 051026085739.htm ...

Common Bronchodilator Drug Linked To Increased Deaths. ScienceDaily . Retrieved June 4, 2025 from www.sciencedaily.com / releases / 2008 / 09 / 080915174609.htm ...